Croissy-Beaubourg and Montpellier, France, 14 June 2017 – 8.00 am CEST – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specialising in in vitro diagnostics and theranostics, is…
Croissy-Beaubourg and Montpellier, May 12, 2017 – 8:00am CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in in vitro diagnostics and theranostics, has successfully completed…
Croissy-Beaubourg and Montpellier, May 11, 2017 – 6:15pm CET – THERADIAG (ISIN: FR0004197747, ticker: ALTER, eligible for PEA-PME equity savings plans in France), a company specializing in in vitro diagnostics and theranostics, is today announcing…